Article content continued

The strategy offered to investors leverages three business units with the intention of providing significant exposure to the entire cannabis chain. Harvest One serves as the umbrella company over its horticultural arm, United Greeneries Holdings Ltd. (UG), and its medical arm, Satipharm AG.

Photo by Supplied

UG holds a Canadian Access to Cannabis for Medical Purposes Regulations (ACMPR) cultivation and sales license, and remains one of only a few companies globally with the capacity to commercially cultivate and sell medicinal grade cannabis in a federally-regulated environment.

UG operates a 16,000-sq.-ft. facility inDuncan, B.C. that’s been licensed under ACMPR since June 2016. The facility is currently undergoing an expansion that will add 15,000 sq. ft. designated for a propagation system that will produce large quantities of rooted cuttings and pre-grown starter plants for all the company’s facilities. Licensing for the expanded site is anticipated in the second quarter of 2018.

Following the recent announcement by the Saskatchewan provincial government on cannabis legalization, UG is advancing its Lucky Lake facility, located about 150 km south of Saskatoon, and offering a potential of 80,000 sq. ft. of cultivation space. The facility is in the final stages of approval by Health Canada, with the initial ACMPR license expected in the third quarter of 2018.

With additional growing facilities under development, Harvest One is gearing up to offer a 20,000-kg production capacity by the end of 2018.